Silgan
SLGN NYSE Metal, Glass & Plastic Containers Financials FY2016βFY2025
Silgan's revenue rose 10.7% to $6.5 billion in fiscal 2025. Its net margin was 4.5%, down from 4.7% a year earlier. Free cash flow was $423 million, down 7.9%. It paid out $161 million in dividends and buybacks, 38% of free cash flow. The diluted share count fell 0.3%.
What Silgan does
No business description yet.
- Legal name
- SILGAN HOLDINGS INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-012202
0000849869
Revenue and margins
Silgan had $6.5B of revenue in fiscal 2025, up 10.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 8.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $423M in fiscal 2025, 6.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Silgan returned $161M to shareholders in fiscal 2025, 38% of free cash flow. The diluted share count fell 0.3%.
Value Silgan yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$3.3B and divides by 106.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 15.4x Β· peers 20.6x Β· sector 20.6x.
Balance sheet
Cash, debt and the ratios that show how comfortably Silgan can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $631M | $586M | $643M | $823M | $1.1B |
| Debt incl. finance leases | $3.9B | $3.5B | $3.5B | $4.2B | $4.4B |
| Net debt / EBITDA | 3.9x | 3.4x | 3.3x | 4.3x | 3.6x |
| Debt / equity | 2.5x | 2.0x | 1.9x | 2.1x | 1.9x |
| Interest coverage | 5.3x | 4.8x | 3.4x | 3.1x | 3.2x |
| Current ratio | 1.5x | 1.5x | 1.0x | 1.1x | 1.2x |
| Quick ratio | 1.0x | 1.0x | 0.6x | 0.7x | 0.8x |
| Total assets | $7.8B | $7.3B | $7.6B | $8.6B | $9.4B |
| Total liabilities | $6.2B | $5.6B | $5.7B | $6.6B | $7.1B |
| Shareholders' equity | $1.6B | $1.7B | $1.9B | $2.0B | $2.3B |
| Net debt (β = net cash) | $3.2B | $2.9B | $2.8B | $3.4B | $3.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.3M
2 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 6 / 9 | 7 / 9 |
| Accruals ratio | β2.1% | β5.5% | β4.9% |
| Altman Z'' | 2.28 | 2.22 | 2.39 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Silgan SLGN | $4.2B | 10.7% | β | 6.5% | 7.6% | 15.4x | 7 | |
| O-I Glass OI | $993M | β1.6% | β | 2.6% | 4.2% | β | 6 | Compare β |
| Greif GEF | β | β9.7% | 4.3% | β2.2% | 1.9% | β | β | Compare β |
| AptarGroup ATR | $8.1B | 5.4% | 13.3% | 7.9% | 11.4% | 22.8x | 7 | Compare β |
| Ball BALL | $17.3B | 11.6% | β | 6.0% | 10.4% | 18.4x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.6B | $4.1B | $4.4B | $4.5B | $4.9B | $5.7B | $6.4B | $6.0B | $5.9B | $6.5B |
| Gross profit | $512M | $635M | $690M | $714M | $867M | $918M | $1.0B | $993M | $1.0B | $1.1B |
| Operating income | $300M | $357M | $412M | $360M | β | β | β | β | β | β |
| Interest expense | $67.8M | $110M | $116M | $106M | $104M | $108M | $126M | $173M | $166M | $189M |
| Pretax income | $232M | $240M | $293M | $252M | $407M | $466M | $474M | $422M | $348M | $409M |
| Income tax | $78.6M | β$30.0M | $69.3M | $58.3M | $98.4M | $107M | $133M | $96.2M | $72.0M | $123M |
| Net income | $153M | $270M | $224M | $194M | $309M | $359M | $341M | $326M | $276M | $288M |
| Diluted EPS | $1.27 | $2.42 | $2.01 | $1.74 | $2.77 | $3.23 | $3.07 | $2.98 | $2.58 | $2.70 |
| Diluted shares | 0.12B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B | 0.11B |
| Cash flow | ||||||||||
| Cash from operations | $395M | $390M | $507M | $507M | $603M | $557M | $748M | $483M | $722M | $730M |
| Capital expenditure | $192M | $174M | $191M | $231M | $224M | $232M | $216M | $227M | $263M | $307M |
| Free cash flow | $203M | $215M | $316M | $276M | $378M | $325M | $533M | $256M | $459M | $423M |
| Depreciation and amortization | $143M | $174M | $192M | $207M | $219M | $250M | $263M | $263M | $276M | $319M |
| Stock-based compensation | $13.0M | $14.6M | β | β | β | β | β | $15.6M | $15.5M | $18.0M |
| Acquisitions | $0.0M | $1.0B | $0.0M | $0.0M | $941M | $746M | $2.5M | $0.0M | $922M | $0.0M |
| Share buybacks | $281M | $4.1M | $7.8M | $27.6M | $42.1M | $8.6M | $45.1M | $184M | $9.3M | $74.9M |
| Dividends paid | $40.9M | $40.5M | $44.5M | $50.8M | $53.6M | $62.5M | $71.9M | $78.9M | $82.1M | $85.8M |
| Dividends and buybacks | $322M | $44.6M | $52.4M | $78.4M | $95.8M | $71.1M | $117M | $263M | $91.4M | $161M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $24.7M | $53.5M | $72.8M | $204M | $410M | $631M | $586M | $643M | $823M | $1.1B |
| Total debt | $1.6B | $2.5B | $2.3B | $2.2B | $3.3B | $3.8B | $3.4B | $3.4B | $4.1B | $4.3B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $33.3M | $34.5M | $68.7M | $65.7M | $63.3M | $41.7M | $38.8M |
| Current assets | $962M | $1.3B | $1.3B | $1.4B | $1.8B | $2.3B | $2.1B | $2.3B | $2.5B | $3.0B |
| Current liabilities | $862M | $958M | $1.1B | $1.0B | $1.2B | $1.5B | $1.4B | $2.3B | $2.2B | $2.5B |
| Inventory | $603M | $721M | $635M | $633M | $678M | $799M | $769M | $941M | $928M | $1.1B |
| Property and equipment, net | $1.2B | $1.5B | $1.5B | $1.6B | $1.8B | $2.0B | $1.9B | $2.0B | $2.3B | $2.4B |
| Total assets | $3.1B | $4.6B | $4.6B | $4.9B | $6.5B | $7.8B | $7.3B | $7.6B | $8.6B | $9.4B |
| Total liabilities | $2.7B | $3.9B | $3.7B | $3.9B | $5.3B | $6.2B | $5.6B | $5.7B | $6.6B | $7.1B |
| Shareholders' equity | $469M | $766M | $881M | $1.0B | $1.3B | $1.6B | $1.7B | $1.9B | $2.0B | $2.3B |
| Margins | ||||||||||
| Gross margin | 14.2% | 15.5% | 15.5% | 15.9% | 17.6% | 16.2% | 16.3% | 16.6% | 17.3% | 17.7% |
| Operating margin | 8.3% | 8.7% | 9.3% | 8.0% | β | β | β | β | β | β |
| EBITDA margin | 12.3% | 13.0% | 13.6% | 12.6% | 14.8% | 14.5% | 13.5% | 14.3% | 13.5% | 14.1% |
| Net margin | 4.2% | 6.6% | 5.0% | 4.3% | 6.3% | 6.3% | 5.3% | 5.4% | 4.7% | 4.5% |
| FCF margin | 5.6% | 5.3% | 7.1% | 6.2% | 7.7% | 5.7% | 8.3% | 4.3% | 7.8% | 6.5% |
| Returns | ||||||||||
| Return on capital | 9.8% | 13.6% | 9.9% | 8.9% | 10.7% | 9.9% | 9.2% | 9.8% | 8.1% | 7.6% |
| Return on capital employed | 12.8% | 12.0% | 11.5% | 9.7% | 11.1% | 9.9% | 9.9% | 10.6% | 8.8% | 9.0% |
| Return on equity | 27.7% | 43.7% | 27.2% | 20.4% | 27.1% | 25.5% | 20.8% | 18.1% | 14.3% | 13.5% |
| Return on assets | 4.8% | 6.9% | 4.9% | 4.1% | 5.4% | 5.0% | 4.5% | 4.4% | 3.4% | 3.2% |
| Growth | ||||||||||
| Revenue growth | β4.0% | 13.2% | 8.8% | 0.9% | 9.6% | 15.3% | 12.9% | β6.6% | β2.2% | 10.7% |
| Net income growth | β11.1% | 75.8% | β16.9% | β13.5% | 59.3% | 16.3% | β5.1% | β4.4% | β15.2% | 4.4% |
| EPS growth | β9.9% | 90.6% | β16.9% | β13.4% | 59.2% | 16.6% | β5.0% | β2.9% | β13.4% | 4.7% |
| FCF growth | 105.8% | 6.3% | 46.5% | β12.4% | 36.9% | β14.2% | 64.1% | β52.0% | 79.5% | β7.9% |
| Share count change | β1.7% | β7.6% | 0.2% | β0.1% | β0.1% | β0.2% | β0.1% | β1.6% | β1.9% | β0.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 3.5x | 4.7x | 3.7x | 3.7x | 3.9x | 3.9x | 3.4x | 3.3x | 4.3x | 3.6x |
| Debt / equity | 3.3x | 3.3x | 2.6x | 2.2x | 2.6x | 2.5x | 2.0x | 1.9x | 2.1x | 1.9x |
| Interest coverage | 4.4x | 3.2x | 3.5x | 3.4x | 4.9x | 5.3x | 4.8x | 3.4x | 3.1x | 3.2x |
| Current ratio | 1.1x | 1.4x | 1.2x | 1.4x | 1.5x | 1.5x | 1.5x | 1.0x | 1.1x | 1.2x |
| Quick ratio | 0.4x | 0.6x | 0.6x | 0.8x | 0.9x | 1.0x | 1.0x | 0.6x | 0.7x | 0.8x |
| Capital allocation | ||||||||||
| Capex / revenue | 5.3% | 4.3% | 4.3% | 5.1% | 4.6% | 4.1% | 3.4% | 3.8% | 4.5% | 4.7% |
| Stock comp / revenue | 0.4% | 0.4% | β | β | β | β | β | 0.3% | 0.3% | 0.3% |
| Payouts / FCF | 158.7% | 20.7% | 16.6% | 28.4% | 25.3% | 21.9% | 22.0% | 102.8% | 19.9% | 38.0% |
| Quality scores | ||||||||||
| Piotroski F-score | 4.0 | 8.0 | 4.0 | 8.0 | 8.0 | 6.0 | 6.0 | 6.0 | 6.0 | 7.0 |
| Altman Z'' | 2.7 | 2.5 | 2.6 | 2.7 | 2.6 | 2.6 | 2.8 | 2.3 | 2.2 | 2.4 |
| Accruals ratio | β7.6% | β3.1% | β6.1% | β6.6% | β5.1% | β2.8% | β5.4% | β2.1% | β5.5% | β4.9% |
Source: SEC EDGAR XBRL filings (CIK 0000849869). Data updated October 14, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.